We are live on
!
Find out more
AHB
Abner Herrman & Brock Portfolio holdings
AUM
$1.05B
Turnover
12.82%
1-Year Est. Return
42.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.01%
1 Year Est. Return
+42.66%
3 Year Est. Return
+139.43%
5 Year Est. Return
+198.75%
10 Year Est. Return
+705.09%
AUM
$682M
AUM Growth
+$19.4M
(+2.9%)
Cap. Flow
-$22.4M
Cap. Flow
% of AUM
-3.29%
Top 10 Holdings %
Top 10 Hldgs %
34.99%
Holding
112
New
13
Increased
38
Reduced
33
Closed
11
Avg Time Held
4.5
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
2.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$18.1M |
| 2 |
Oracle
ORCL
|
+$16.4M |
| 3 |
Netflix
NFLX
|
+$16M |
| 4 |
Advanced Micro Devices
AMD
|
+$15.1M |
| 5 |
Amazon
AMZN
|
+$13.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$15.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$14.1M |
| 3 |
Emerson Electric
EMR
|
+$12.6M |
| 4 |
MetLife
MET
|
+$10.7M |
| 5 |
Keurig Dr Pepper
KDP
|
+$7.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.9% |
| 2 | Financials | 18.76% |
| 3 | Healthcare | 13.52% |
| 4 | Industrials | 10.98% |
| 5 | Consumer Discretionary | 9.81% |
Similar funds
PSCM
WCM
FPI
FFM
FMP
PGA
CIP
MPMG
Abner Herrman & Brock's Q2 2023 Portfolio in Review
As of Q2 2023, Abner Herrman & Brock held 112 positions worth $682M, up 2.9% from $662M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Abner Herrman & Brock withdrew a net $22.4M in Q2 2023, closing 11 positions and reducing 33 holdings. Its most notable exit was Target, an estimated $15.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Abner Herrman & Brock opened a new position in Salesforce worth $18.8M.
- Abner Herrman & Brock's largest Q2 2023 buy was Salesforce: 88,814 shares worth $18.8M.
- Abner Herrman & Brock added most to Oracle in Q2 2023, an estimated $16.4M increase.
- Abner Herrman & Brock's biggest Q2 2023 reduction was Bristol-Myers Squibb, cutting an estimated $14.1M.
- Abner Herrman & Brock fully exited Target in Q2 2023, selling an estimated $15.9M.
- Abner Herrman & Brock's ten largest holdings make up 35% of its $682M portfolio in Q2 2023.
- Abner Herrman & Brock opened 13 new positions and closed 11 in Q2 2023.
- Abner Herrman & Brock's portfolio value rose 2.9% quarter-over-quarter to $682M.
Based on Abner Herrman & Brock's 13F filing for Q2 2023, filed 5 Jul 2023.